Arix Bioscience PLC | WebDisclosure

PRESS RELEASE

published on 07/17/2023 at 16:00, 2 years 4 months ago

Holding(s) in Company
PRESS RELEASE

published on 07/13/2023 at 08:01, 2 years 5 months ago

Arix Announces Strategic Review
PRESS RELEASE

published on 07/13/2023 at 08:00, 2 years 5 months ago

Unaudited NAV for June 2023
PRESS RELEASE

published on 06/23/2023 at 15:03, 2 years 5 months ago

Portfolio company Disc Medicine raises $157.8 million in public offering
PRESS RELEASE

published on 06/09/2023 at 15:53, 2 years 6 months ago

Portfolio company Disc Medicine presents positive initial data from Phase 2 BEACON trial at EHA
PRESS RELEASE

published on 06/09/2023 at 08:00, 2 years 6 months ago

Unaudited NAV for May 2023
PRESS RELEASE

published on 05/24/2023 at 08:00, 2 years 6 months ago

Correction: Result of Annual General Meeting
PRESS RELEASE

published on 05/23/2023 at 17:30, 2 years 6 months ago

Result of Annual General Meeting
PRESS RELEASE

published on 05/16/2023 at 17:36, 2 years 6 months ago

Portfolio company Ensoma announces closing of Series B Extension
PRESS RELEASE

published on 05/12/2023 at 08:00, 2 years 7 months ago

Unaudited NAV for April 2023

Published on 12/12/2025 at 18:00, 21 hours 57 minutes ago

Disclosure of trading in own shares between November 24th and November 28th, 2025
Published on 12/12/2025 at 18:00, 21 hours 57 minutes ago

Déclaration des transactions sur actions propres réalisées du 24 novembre au 28 novembre 2025
Published on 12/12/2025 at 09:15, 1 day 6 hours ago

CHANGE IN THE SHARE CAPITAL
Published on 12/12/2025 at 09:15, 1 day 6 hours ago

MODIFICATION DE CAPITAL
Published on 12/11/2025 at 19:23, 1 day 20 hours ago

Eiffage is joining the CAC 40 index

News